Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.75K Sell
9
-9
-50% -$1.86K ﹤0.01% 976
2026
Q1
$4.04K Hold
18
﹤0.01% 787
2025
Q4
$4.34K Sell
18
-2
-10% -$511 ﹤0.01% 831
2025
Q3
$5.47K Sell
20
-47
-70% -$12.8K ﹤0.01% 749
2025
Q2
$17.3K Sell
67
-17
-20% -$4.05K ﹤0.01% 684
2025
Q1
$18.8K Buy
+84
New +$19.6K ﹤0.01% 704
2024
Q3
Sell
-13
Closed -$2.49K 638
2024
Q2
$2.49K Sell
13
-278
-96% -$56.4K ﹤0.01% 583
2024
Q1
$57.6K Buy
+291
New +$53.3K ﹤0.01% 360

Other funds holding RMD

SouthState Corp's RMD Position: Q2 2026 in Review

SouthState Corp reduced its ResMed (RMD) stake by 50% in Q2 2026, selling an estimated $1.86K and leaving 9 shares worth $1.75K. The position accounts for ﹤0.01% of the portfolio, ranked #976.

SouthState Corp first reported a position in RMD in Q1 2024 and has held it in 8 quarters since. The position peaked at $57.6K in Q1 2024. 887 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • SouthState Corp held 9 shares of ResMed worth $1.75K as of Q2 2026.
  • SouthState Corp sold 9 ResMed shares in Q2 2026, an estimated $1.86K.
  • ResMed made up ﹤0.01% of SouthState Corp's portfolio in Q2 2026, its #976 holding.
  • SouthState Corp first reported a position in ResMed in Q1 2024 and has held it in 8 quarters since.
  • SouthState Corp's ResMed position peaked at $57.6K in Q1 2024.
  • 887 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on SouthState Corp's 13F filing for Q2 2026, filed 6 Aug 2026.